More functional DNA in mitochondria cures male infertility
Max Planck Institute for Biology of Ageing
Worldwide approximately nine percent of women and men are involuntarily childless. In 40 to 50 percent of the cases this is due to male infertility. This infertility can be caused by different reasons, one of them are mutations in the mitochondrial DNA. Mitochondria are tiny energy factories inside the cell and harbor their own independent genome – the mitochondrial DNA (mtDNA). Mice suffering from a high number of mutations in the mtDNA are infertile and have fewer and less motile sperm.
Max Planck scientist Min Jiang and her colleagues studied these mice and found a way to overcome the consequences of these mutations. ”We increased the total amount of mtDNA in the mitochondria of the testis. This did not change the proportion of mtDNA with mutations, but it increased the absolute number of non-mutated mtDNA, which restored mitochondrial energy production and semen quality”, explains Jiang.
As a next step the researchers want to screen for pharmaceuticals, which could stimulate total mtDNA amount in the testis. “We hope to find an efficient future strategy to treat or even cure patients suffering from infertility caused by mtDNA mutations”, says Jiang.
Original publication
Min Jiang, Timo Eino Sakari Kauppila, Elisa Motori, Xinping Li, Ilian Atanassov, Kat Folz-Donahue, Nina Anna Bonekamp, Sara Ruth Albarran-Gutierrez, James Bruce Stewart, Nils-Göran Larsson; "Increased total mtDNA copy number cures male infertility despite unaltered mtDNA mutation load"; Cell Metabolism; 1 Aug 2017
Original publication
Min Jiang, Timo Eino Sakari Kauppila, Elisa Motori, Xinping Li, Ilian Atanassov, Kat Folz-Donahue, Nina Anna Bonekamp, Sara Ruth Albarran-Gutierrez, James Bruce Stewart, Nils-Göran Larsson; "Increased total mtDNA copy number cures male infertility despite unaltered mtDNA mutation load"; Cell Metabolism; 1 Aug 2017
Organizations
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.